Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Insulin Detemir Plus Insulin Aspart With Insulin NPH Plus Human Soluble Insulin in Subjects With Type 1 Diabetes

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Type 1 diabetes for at least 12 months~* Current treatment with any basal/bolus regimen or any biphasic insulin treatment for at least 6 months~* BMI below or equal to 35 kg/m\^2~* HbA1c below or equal to 12%~Exclusion Criteria:~* Proliferative retinopathy or maculopathy requiring acute treatment~* Recurrent major hypoglycaemia that may interfere with trial participation (as judged by the Investigator)~* Subjects with known hypoglycaemic unawareness as judged by the Investigator

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Basal/bolus regimen 1 (Type: EXPERIMENTAL): None
- Basal/bolus regimen 2 (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).